Original Research
Published on 13 Jan 2023
Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer
- 2,885 views
- 1 citation
Original Research
Published on 13 Jan 2023
Case Report
Published on 13 Jan 2023
Original Research
Published on 13 Jan 2023
Original Research
Published on 13 Jan 2023
Original Research
Published on 13 Jan 2023
Original Research
Published on 13 Jan 2023
Original Research
Published on 13 Jan 2023
Original Research
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Editorial
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Case Report
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Case Report
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Correction
Published on 12 Jan 2023
Case Report
Published on 12 Jan 2023
Original Research
Published on 12 Jan 2023
Review
Published on 12 Jan 2023
Case Report
Published on 12 Jan 2023